If you've ever wondered why a generic medicine costs ₹20 in one pharmacy and ₹80 in another—or why the government can (or cannot) cap what pharma companies charge—you're looking at…
India's drug regulator, the Central Drugs Standard Control Organisation (CDSCO), is pushing forward with the most significant digital overhaul of its drug approval system in years. The Central Drugs Laboratory…
Buying Indian generic medicines across borders is one of the smartest ways to cut long-term healthcare costs, but the process is only smooth when you understand the customs, documentation and…
India's drug regulator, the Central Drugs Standard Control Organisation (CDSCO), has granted AstraZeneca permission to market its HER2-targeting cancer therapy Enhertu (trastuzumab deruxtecan) for a new, expanded breast cancer indication,…